Core Insights - Insurance capital management is increasingly focused on deep research of individual stocks and industries, with significant interest in A-share listed companies as indicated by over 300 companies being researched since the beginning of 2026 [1][2] Group 1: Research Trends - A total of 96 insurance companies and 32 insurance asset management companies have participated in the research of A-share listed companies since the beginning of 2026 [2] - Key players such as Taiping Pension, Changjiang Pension, and China Life Pension have conducted over 30 research sessions each within a month [2] - Regional banks and sectors like electronic components, semiconductor materials, and devices are receiving heightened attention from insurance capital [2] Group 2: Investment Strategies - Insurance capital views company research as a crucial part of investment strategy, often focusing on high-quality stocks with long-term growth potential [3] - The demand for high dividend stocks is driven by the need for stable cash flow in a low-interest-rate environment, with banks being a primary focus for insurance capital [4] - Insurance capital is increasingly adopting a dividend strategy, favoring high dividend stocks to stabilize returns amid pressure on fixed-income yields [4] Group 3: Focus on New Productive Forces - Insurance capital is aligning with long-term investments in new productive forces, particularly in technology innovation and emerging strategic industries [5] - There is a focus on investing in sectors with real technological barriers and clear business models that can deliver performance [5] Group 4: Investment Paths - For mature technology leaders, insurance capital is likely to invest directly for excess returns, while for emerging tech sectors, indirect investments through ETFs or industry funds are preferred to manage risks [6] - The insurance capital sector is particularly interested in AI-driven technology and high-end manufacturing, with a strategy to invest in companies with clear business models and strong competitive advantages [6]

Group 1 - The core viewpoint of the articles highlights the increasing interest of insurance capital in specific sectors and companies, particularly in regional banks and new productivity sectors, as indicated by their extensive research activities [1][2][3] - Since the beginning of 2026, over 300 A-share listed companies have been researched by insurance companies and asset management firms, with significant participation from 96 insurance companies and 32 asset management companies [2] - Key areas of focus for insurance capital include regional banks such as Shanghai Bank and Nanjing Bank, as well as sectors like electronic components, semiconductor materials, and devices [2][3] Group 2 - Insurance capital is increasingly favoring high-dividend stocks as a stable source of cash flow, particularly in a low-interest-rate environment, which drives the demand for equity assets [4] - The strategy of investing in high-dividend stocks is seen as a way to enhance returns and stabilize portfolios, with a focus on long-term holdings and dividend yields [4][5] - The shift towards high-dividend stocks is also a response to new accounting standards that increase profit statement volatility, making these investments more attractive [4] Group 3 - Insurance capital is aligning with the new productivity sector, which relies on technological innovation and strategic emerging industries, requiring long-term and stable capital support [5][6] - Investments are being directed towards technology leaders with clear business models and performance track records, while emerging tech sectors may be approached through industry-themed ETFs or funds to mitigate risks [6] - The focus on AI-driven technology and high-end manufacturing is expected to be central to future technological revolutions, with a commitment to direct investments in companies with strong competitive advantages [6]

● 本报记者 薛瑾 "无论是配置盘还是交易盘，险资投资框架都是基于对个股和行业的深度研判。"一位保险资管人士日前 在接受中国证券报记者采访时表示。作为对个股和行业研判的重要环节，上市公司调研透露出险资一段 时间内的兴趣点。Wind数据显示，2026年开年以来，保险公司及保险资管公司合计调研A股上市公司逾 300家。从调研标的分布来看，部分区域性银行和新质生产力领域个股备受险资关注。 调研个股透露险资偏好 从调研机构看，截至2月5日，2026年以来有96家保险公司、32家保险资产管理公司参与调研A股上市公 司。保险公司中，太平养老、长江养老、国寿养老、人保养老在一个多月的时间里调研次数均超过30 次。保险资管公司中，泰康资产、华泰资产、新华资产、人保资产、国寿资产、大家资产调研次数居 前，也均达到30次以上。 从调研对象来看，部分区域性银行以及电子元件、电子设备和仪器、半导体材料与设备等领域关注度颇 高。 上海银行、南京银行、苏州银行、齐鲁银行、厦门银行等多家区域性银行，均位列险资调研行列，上海 银行被14家保险公司及保险资管公司调研，南京银行也得到10家保险公司及保险资管公司调研。息差变 化及管理举措、投资策 ...

Group 1 - Institutional research activity has increased significantly in 2023, with over 700 listed companies receiving institutional visits from January 1 to February 5 [1] - Key sectors attracting institutional attention include computer, machinery, pharmaceuticals, and electronics, with companies like Daikin Heavy Industries, Beijing Haitai Ruisheng Technology, and Henan Xiangyu Medical Equipment hosting over 200 institutional visits [1] - Emerging technologies such as AI computing infrastructure, brain-computer interface technology commercialization, and global energy transition are focal points for institutional investors [1] Group 2 - Daikin Heavy Industries is the first listed company in China's wind power tower industry, with a strong market share in the German offshore wind sector and successful project delivery [2] - The company has secured a local service base at the port of Cuxhaven in Germany and has completed its market layout in Poland, with local installation and inspection experience [2] - The focus of institutional research on computer, pharmaceuticals, and electronics sectors reflects a transition from conceptual phases to performance realization in emerging technologies [2]

格隆汇2月5日丨翔宇医疗(688626.SH)在互动平台表示，公司基于自主研发和具备行业内较全体系的康 复装备基础，可快速实现"脑机接口技术+自有康复设备"的深度融合，提供脑机接口赋能的整体解决方 案，相关产品已进入600多家三甲医院，持续保持公司在行业内的竞争优势。 但招投标和销售等具有滞 后性，截至2025年末，公司脑机接口相关产品实现营收占比较小。 ...

Core Insights - The article highlights the accelerated pace of institutional research on A-share listed companies as they release their 2025 performance forecasts, indicating a proactive approach to investment strategies for the new year [1] Group 1: Institutional Research Trends - Over 700 A-share listed companies have received institutional research since the beginning of the year, with over 20 companies attracting more than 100 institutions each [1] - Key sectors attracting attention include electronics, machinery, and pharmaceuticals, with power equipment and non-ferrous metals also being closely monitored [1] Group 2: New Product Launches - Several companies have announced accelerated timelines for new product mass production, showcasing confidence in growth for the new year [2] - Nepean Mining revealed plans to globally promote its innovative composite liner product in 2026, supported by the gradual production ramp-up of overseas facilities [2] - Huqin Technology's robotics division is set to deliver mass-produced robots in 2026, following significant advancements in R&D and project execution [2] - Jiemai Technology is investing in a production line for critical products, with mass production expected by mid-2026 [2] Group 3: Brain-Computer Interface Developments - Companies like Xiangyu Medical and Aipeng Medical are focusing on brain-computer interface technologies, with Xiangyu Medical planning to launch nearly 100 products by the end of 2026 [3] - The integration of software with rehabilitation equipment is expected to enhance product offerings and market competitiveness [3] Group 4: Industry Expansion and Growth - The demand for AI and computing power is driving growth in sectors like optical communication and liquid cooling, prompting companies to accelerate production capacity [4] - Daikin Heavy Industries reported a tight production schedule for overseas projects, anticipating significant growth in offshore wind energy markets [4] - Zhongji Xuchuang noted a strong order backlog extending into Q4 2026, indicating sustained high demand in the industry [4] Group 5: Storage and Liquid Cooling Innovations - Dike Technology plans to increase its storage chip output target to between 30 million and 50 million units in 2026, aiming to enhance revenue and net profit [5] - Dingtong Technology is expanding its liquid cooling production capabilities to meet rising customer demand [5] - Haitai Ruisheng is building a second overseas delivery base in Southeast Asia, expected to support significant orders from major tech clients [5] Group 6: Mergers and Acquisitions - Companies are increasingly pursuing mergers and acquisitions to enter new markets and drive growth [6] - Yingtang Zhikong plans to acquire Guanglong Integration and Aojian Microelectronics to enter the optical communication sector [6] - Dinglong Co. is acquiring Haofei New Materials to tap into the lithium battery functional materials market, with expected sales growth in 2026 [6] Group 7: Strategic Investments - Tianlu Technology is reallocating funds to projects aimed at enhancing its product offerings in the display industry, with equipment for the TAC film project expected to be operational by mid-2026 [7]

Core Insights - The article highlights the accelerated pace of institutional research on A-share listed companies as they prepare for investment opportunities in 2026, with over 700 companies receiving institutional inquiries since the beginning of the year [2] Group 1: Institutional Research Trends - More than 700 A-share listed companies have been visited by institutional investors for research since the start of 2026, with over 20 companies attracting more than 100 institutions each [2] - Key sectors attracting attention include electronics, machinery, pharmaceuticals, power equipment, and non-ferrous metals [2] Group 2: New Product Launches - Several companies have announced timelines for mass production of new products, indicating a strong growth outlook for 2026 [3] - Nepean Mining revealed plans to globally promote its innovative composite lining board, with production ramping up in 2026 [3] - Huajin Technology's robotics division is set to deliver mass-produced robots in 2026, enhancing flexible manufacturing capabilities [3] - Jiemai Technology is investing in a production line for critical products, expected to achieve scale production by mid-2026 [3] Group 3: Brain-Computer Interface Developments - Companies like Xiangyu Medical are focusing on brain-computer interface technologies, with plans to launch nearly 100 products by the end of 2026 [4] - The integration of software with rehabilitation equipment is expected to enhance product offerings and reduce upgrade cycles [4] Group 4: High-Growth Sector Expansion - The demand for AI and computing power is driving growth in sectors like optical communication and liquid cooling, prompting companies to accelerate production capacity [5] - Daikin Heavy Industries reported a tight production schedule for overseas projects, anticipating significant growth in offshore wind energy markets [5] - Zhongji Xuchuang noted a strong order backlog extending into Q4 2026, indicating sustained demand in the optical module sector [5] Group 5: Storage and Liquid Cooling Innovations - Dike Technology plans to increase its storage chip output target to between 30 million and 50 million units in 2026, aiming for significant revenue growth [6] - Dingtong Technology is expanding its liquid cooling production capacity to meet rising customer demand [6] - Haitan Ruisheng is enhancing its overseas operations, planning to establish a second local delivery base in Southeast Asia by the end of 2026 [6] Group 6: Mergers and Acquisitions for Growth - Companies are increasingly pursuing acquisitions to enter new markets and drive business transformation [7] - Yingtang Zhikong plans to acquire Guanglong Integration and Ao Jian Microelectronics to enter the optical communication sector [7] - Dinglong Co. is acquiring Haofei New Materials to expand into the lithium battery materials market, with expected sales growth in 2026 [7] - Tianlu Technology is reallocating funds to projects aimed at enhancing its product offerings in the display industry [8]

Group 1 - Laplace's stock price surged by 105% since January 5, 2026, with a closing price of 73.90 yuan and a market capitalization of 29.48 billion yuan as of February 4 [1] - The company specializes in the research and sales of core equipment for high-efficiency photovoltaic cell production, achieving significant market share in thermal processing, coating, and automation equipment [3] - In January, 112 companies on the Sci-Tech Innovation Board received institutional research, with a focus on sectors such as semiconductors, medical devices, and specialized equipment [3] Group 2 - In January, 56 institutions conducted a total of 1,221 "buy" ratings covering 653 stocks, with 40 stocks receiving ratings from at least five institutions [4] - The banking and food and beverage sectors had the highest number of rated stocks, with 7 and 6 stocks respectively, as low valuation bank stocks attracted institutional attention [4] - The average return for billion-level quantitative private equity in 2025 reached 32.77%, with some firms achieving returns over 50% [5] Group 3 - Several small and medium-sized banks have raised deposit rates, while others have chosen to lower rates amid a declining market interest rate environment [6] - The total market capitalization of cryptocurrencies has decreased by approximately 467.6 billion dollars since January 29, despite supportive stances from the White House [7]

（编辑 任世碧） 证券日报网讯 2月4日，翔宇医疗在互动平台回答投资者提问时表示，2025年12月，翔宇工业旅游景区 获评国家4A级旅游景区，标志着景区在旅游资源开发、服务品质提升、文化内涵挖掘等方面获得认 可，也为安阳"中国康复设备之都"品牌再添文旅亮色。 ...

Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical and biotechnology industry [1] Core Insights - The medical device bidding market is expected to maintain high prosperity in 2025, driven by policy and demand resonance, with a projected market size of CNY 193.76 billion, representing a year-on-year growth of 24% [3][11] - The upward trend for medical device companies is clear for 2026, with multiple policies expected to support the continuous development of medical innovation [4][29] - The report emphasizes the importance of high-end product localization and innovation in driving growth for leading domestic companies [33][41] Summary by Sections Bidding Review - The medical device bidding market in 2025 is projected to reach CNY 193.76 billion, with a year-on-year increase of 24%, second only to the peak in 2022 [3][11] - Monthly bidding trends show sustained high levels, with procurement amounts from July to December ranging from CNY 134 billion to CNY 285 billion [3][11] - Key segments such as medical imaging equipment and radiation therapy devices are expected to see significant growth, with year-on-year increases of 35.37% and 36.34% respectively [3][16] 2026 Outlook - The report anticipates a clear upward turning point for medical device companies in 2026, supported by policies aimed at promoting medical innovation and equipment updates [4][29] - The implementation of large-scale equipment updates and consumer replacement policies is expected to further stimulate market demand [4][29] - The report highlights the potential for domestic companies to benefit from high-end product upgrades and the commercialization of brain-computer interface technologies [4][50] Investment Recommendations - The report suggests focusing on leading domestic companies that are enhancing their high-end and intelligent medical device offerings, such as Mindray, United Imaging, and KaiLi Medical [4][33] - It also recommends monitoring companies involved in brain-computer interfaces and domestic robotics, which are expected to see significant growth in the coming years [4][50]